Brief: Marinus Pharmaceuticals - Cash Runway Projected Into Q4 2024

Marinus Pharmaceuticals

07/11/2023 12:19

Nov 7 (Reuters) - Marinus Pharmaceuticals Inc  MRNS.O :
    * MARINUS PHARMACEUTICALS - CASH RUNWAY PROJECTED INTO Q4
2024
WITH CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $176.4
MILLION AS OF SEPT 30, 2023
    * NOW EXPECTS 2023  ZTALMY NET PRODUCT REVENUES OF BETWEEN
$18.5
MILLION AND $19 MILLION
    * QTRLY  LOSS PER SHARE $0.61
    * Q3 EARNINGS PER SHARE VIEW $-0.66 -- LSEG IBES DATA

Source text for Eikon:  ID:nBw5h2Fhxa 
Further company coverage:  MRNS.O 

 ((Reuters.Briefs@thomsonreuters.com;))